The findings mean that for those using preexposure prophylaxis with gender-affirming hormone therapy or long-acting hormonal ...

Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...

Introduction Saskatchewan is facing a public health crisis driven by high rates of HIV, syphilis and hepatitis C virus (HCV) infections, particularly among people who use drugs. Injection drug use is ...

The city's axess sexual health service is piloting a new online platform that will deliver preventative HIV medication PrEP ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

ViiV Healthcare, a healthcare company founded by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), announced on Wednesday that its long-acting HIV PrEP therapy cabotegravir was found to be more acceptable to ...

The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.

Injectable PrEP is coming to the UK, as the National Institute for Health and Care Excellence (NICE) has approved cabotegravir (Apretude) – a groundbreaking development against HIV/AIDS. The rollout ...

It’s possible to produce a generic version of lenacapavir, a twice-yearly antiretroviral injection that both prevents and treats HIV, for as little as $25 per patient per year, according to a study ...

Rapper Cardi B recently got candid with her followers about HIV and the importance of caring for one's health and well-being. During a livestream video, the mother of three also urged her followers to ...

In what health authorities are calling a game-changer, the United Kingdom has approved a long-acting HIV prevention injection to be administered every two months as an alternative to daily oral ...

An injection to prevent HIV is to be offered to patients on the NHS in England and Wales for the first time, bringing the policy in line with Scotland. The long-acting shot, given six times a year or ...